Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Approaches to Gene Modulation Therapy for ALS

Neurotherapeutics(2022)10.1007/s13311-022-01285-wSource: DataRank Database

Approaches to Gene Modulation Therapy for ALS is a research paper published in Neurotherapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: bronzeTopics (27)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Robert H. Brown ORCID,Katharina E. Meijboom ORCID

Live enrichment

PubMed:36068427

NIH Clinical Center

Grant: R01 NS111990

National Institutes of Health

Grant: 5R01NS111990-03

Next-generation antisense therapeutics for ALS and frontotemporal dementia

bronzeLicense: Elsevier Non-Commercial

publisherhttps://link.springer.com/content/pdf/10.1007/s13311-022-01285-w.pdf

publisherhttps://link.springer.com/article/10.1007/s13311-022-01285-w/fulltext.html

publisherhttps://api.elsevier.com/content/article/PII:S1878747923010747?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1878747923010747?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9587165

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesHumansAmyotrophic Lateral SclerosisSuperoxide Dismutase-1C9orf72 ProteinOligonucleotides, AntisenseMicroRNAs

MeSH Terms

HumansAmyotrophic Lateral SclerosisSuperoxide Dismutase-1C9orf72 ProteinOligonucleotides, AntisenseMicroRNAs

Keywords

MicroRNAsSuperoxide Dismutase-1C9orf72 ProteinAmyotrophic Lateral SclerosisHumansOligonucleotides, AntisenseAdeno-associated virus (AAV)Amyotrophic lateral sclerosis (ALS)Antisense oligonucleotides (ASOs)CRISPR/Cas9Gene therapyMicroRNA

Sustainable Development Goals

SDG 3: 3. Good health